GeorgiaBio: Altea & KAI Pharma Enter into a Preclinical and Clinical Development Agreement for the Transdermal Delivery of Certain Novel KAI Peptides
Posted using ShareThis
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Georgia Bio (GaBio), is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. Georgia’s life sciences community is a rich mix of companies applying life sciences technologies to improving medicine and healthcare, agriculture, industrial and energy production, forestry, marine science and environmental management.
Georgia Bio News
Georgia Bio Event Listing
BIO Press Releases
Blog Archive
-
▼
2010
(33)
-
▼
January
(10)
- Emory Will Partner with GlaxoSmithKline on Drug Re...
- Fort McPherson’s biotech makeover moves forward
- Sciele Pharma, Inc., a Shionogi Group Company, Ann...
- Last-ditch lobbying battle over biotech drugs | a...
- IBB Recognized in National Academies Report/Video
- IBB Recognized in National Academies report/video
- GeorgiaBio: Solvay Pharmaceuticals, Aerovectrx CEO...
- GeorgiaBio: Altea
- GeorgiaBio: Industry, Workforce Leaders, GA Dept. ...
- GeorgiaBio: GaBio Names Sapna Hornyak of Clinimetr...
-
▼
January
(10)
About Me
- GaBio Admin
- Atlanta, Georgia
- Georgia Bio (GaBio), founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. Members include companies, universities, research institutions, government groups and other industry associations involved in discovery and application of life sciences products and related services that improve the health and well-being of people throughout the world. Visit www.gabio.org to learn more and become a member.
Posts
No comments:
Post a Comment